LONDON, July 31 (Reuters) – AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a $118 billion takeover approach from rival…

from Reuters: Mergers News http://ift.tt/UMWs5b
via IFTTT

Publicités